Pathological and serum-enzyme changes after epinephrine in oil and adrenergic blocking agent.
D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D000818:Animals; D001219:Aspartate Aminotransferases; D001769:Blood; D001806:Blood Urea Nitrogen; D004837:Epinephrine / Q000009:adverse effects*; D005634:Fructose-Bisphosphate Aldolase; D006331:Heart Diseases / Q000209:etiology*; D007674:Kidney Diseases / Q000209:etiology*; D008107:Liver Diseases / Q000209:etiology*; D008171:Lung Diseases / Q000209:etiology*; D009135:Muscular Diseases / Q000209:etiology*; D009821:Oils / Q000009:adverse effects*; D010643:Phenoxybenzamine / Q000494:pharmacology*; D051381:Rats; D014508:Urea
D009821:Oils; D010643:Phenoxybenzamine; D014508:Urea; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D005634:Fructose-Bisphosphate Aldolase; D004837:Epinephrine